Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.49 USD | +4.67% | +3.18% | -44.01% |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Apr. 22 | Acadia Pharmaceuticals' Rett Syndrome Treatment Granted Priority Review by Health Canada | MT |